Projecte Dels Noms-Hispanosida
- Address
- Calle Del Comte Borrell 164 166 Bajo, 08015 Barcelona, Spain
Bacterial Infections and Mycoses
At Projecte Dels Noms‑Hispanosida, researchers are focusing on bacterial infections such as syphilis. The trials aim to evaluate new oral antibiotic options that could match the effectiveness of standard treatments, improving convenience and expanding therapeutic choices.
- Non‑inferiority assessment of oral linezolid versus benzathine penicillin for early syphilis
- Exploration of alternative antimicrobial regimens for bacterial sexually transmitted infections
The site’s dedicated team of three investigators is advancing treatment strategies for sexually transmitted bacterial diseases.
Virus Diseases
The virology program at Projecte Dels Noms‑Hispanosida investigates herpes simplex virus infections, seeking safer and more effective immunotherapies. Trials evaluate safety, immune response, and efficacy of a novel targeted immunotherapy designed to lower the risk of recurrent genital herpes episodes.
- Safety and reactogenicity profiling of a targeted HSV immunotherapy
- Efficacy study on reducing HSV‑2 genital recurrence rates
These studies support the development of innovative therapies for viral sexually transmitted infections at the Barcelona research site.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GlaxoSmithKline Biologicals2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Projecte Dels Noms-Hispanosida
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection. | Gilead Sciences Inc. | Phase III | Not Recruiting | Dec 2016 | Jul 2026 |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Benzathine Benzylpenicillin | 1 | Unknown | 2021-10-07 | 2021-10-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.